Search
Purple Biotech Ltd
PPBTAdd to Watchlist
1.630USD
+0.070+4.49%
Close 11-13 16:00（ET）
1.52MMarket Cap
LossP/E TTM
About Purple Biotech Ltd Company
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
Purple Biotech Ltd Profile
Ticker SymbolPPBT
Company namePurple Biotech Ltd
IPO dateSep 03, 1978
CEOEfron (Gil)
Number of employees9
Security typeDepository Receipt
Fiscal year-endSep 03
Address4 Oppenheimer St.
CityREHOVOT
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryIsrael
Postal code7670104
Phone97239333121
Websitehttps://purple-biotech.com/
Ticker SymbolPPBT
IPO dateSep 03, 1978
CEOEfron (Gil)
Company Executives of Purple Biotech Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Director
Director
3.06M
--
Mr. Avraham Ben-Tzvi
Mr. Avraham Ben-Tzvi
General Counsel, Secretary
General Counsel, Secretary
--
--
Mr. Shai Lankry, CPA
Mr. Shai Lankry, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Suzana Nahum-Zilberberg, CPA
Ms. Suzana Nahum-Zilberberg, CPA
Director
Director
--
--
Dr. Michael Schickler, Ph.D.
Dr. Michael Schickler, Ph.D.
Head of Clinical Operations
Head of Clinical Operations
--
--
Dr. Bertrand Liang
Dr. Bertrand Liang
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Eric K. Rowinsky, M.D.
Dr. Eric K. Rowinsky, M.D.
Chairman of the Board
Chairman of the Board
--
--
Mr. Gil Efron, CPA
Mr. Gil Efron, CPA
Director
Director
--
--
Dr. Hadas Reuveni
Dr. Hadas Reuveni
Founder and Chief Technology Officer of TyrNovo (a subsidiary)
Founder and Chief Technology Officer of TyrNovo (a subsidiary)
--
--
Mr. Itzhak Israel
Mr. Itzhak Israel
Director
Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Director
Director
3.06M
--
Mr. Avraham Ben-Tzvi
Mr. Avraham Ben-Tzvi
General Counsel, Secretary
General Counsel, Secretary
--
--
Mr. Shai Lankry, CPA
Mr. Shai Lankry, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Suzana Nahum-Zilberberg, CPA
Ms. Suzana Nahum-Zilberberg, CPA
Director
Director
--
--
Dr. Michael Schickler, Ph.D.
Dr. Michael Schickler, Ph.D.
Head of Clinical Operations
Head of Clinical Operations
--
--
Dr. Bertrand Liang
Dr. Bertrand Liang
Chief Medical Officer
Chief Medical Officer
--
--
FAQs
Who are the top five shareholders of Purple Biotech Ltd?
The top five shareholders of Purple Biotech Ltd are: Mr. Robert E. (Rob) Gagnon
How many institutions hold shares of Purple Biotech Ltd (PPBT)?
As of 2026Q1, 40 institutions hold shares of Purple Biotech Ltd, with a combined market value of approximately 121.71K, accounting for 13.10% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 86679.00.